HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a bioassay as a measure of drozitumab-mediated apoptosis induced by soluble Fc gamma receptors.

Abstract
Drozitumab is an agonistic therapeutic monoclonal antibody (mAb) against the pro-apoptotic death receptor 5 (DR5). In vitro cell killing assays using drozitumab have traditionally required cross-linking with anti-Fc antibody to amplify the pro-apoptotic signal, although drozitumab shows activity in in vivo tumor models without artificial cross-linking. Recently it has been shown that FcγR expressing cells play an important role in the activity of drozitumab by mediating cross-linking in vivo (Wilson et al., 2011). To provide a more biologically relevant alternative to cross-linking with anti-Fc antibody in in vitro bioassays, methods for cross-linking with soluble FcγR extracellular domain (ECD) were developed in this work. FcγR cross-linking methods developed in this work were assessed in solution, bead-bound, and plate-bound assay formats, as well as a cell-based assay format. The assays showed reproducible drozitumab dose-response curves in the concentration range of 5-20,000ng/mL and had acceptable precision and accuracy. The assays are also able to detect degradative changes in drozitumab samples subjected to thermal stress. The data suggest that FcγR cross-linking of drozitumab is a viable alternative to anti-Fc cross-linking of drozitumab to measure effector mediated apoptosis of drozitumab in vitro.
AuthorsJeongsup Shim, Ally Huang, Aaron S Miller
JournalJournal of immunological methods (J Immunol Methods) Vol. 448 Pg. 26-33 (09 2017) ISSN: 1872-7905 [Electronic] Netherlands
PMID28506821 (Publication Type: Evaluation Study, Journal Article)
CopyrightCopyright © 2017 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptors, IgG
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • TNFRSF10B protein, human
  • drozitumab
Topics
  • Antibodies, Monoclonal (chemistry, metabolism, pharmacology)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (chemistry, metabolism, pharmacology)
  • Apoptosis (drug effects)
  • Coculture Techniques
  • Dose-Response Relationship, Drug
  • Drug Stability
  • HEK293 Cells
  • Hot Temperature
  • Humans
  • Immunoassay (methods)
  • Jurkat Cells
  • Microscopy
  • Protein Binding
  • Protein Denaturation
  • Protein Interaction Domains and Motifs
  • Protein Stability
  • Receptors, IgG (chemistry, immunology, metabolism)
  • Receptors, TNF-Related Apoptosis-Inducing Ligand (antagonists & inhibitors, immunology, metabolism)
  • Reproducibility of Results
  • Signal Transduction (drug effects)
  • Surface Plasmon Resonance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: